Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Assets (2020 - 2025)

Historic Assets for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $84.4 million.

  • Rapid Micro Biosystems' Assets fell 2025.26% to $84.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.4 million, marking a year-over-year decrease of 2025.26%. This contributed to the annual value of $98.2 million for FY2024, which is 3156.67% down from last year.
  • Rapid Micro Biosystems' Assets amounted to $84.4 million in Q3 2025, which was down 2025.26% from $75.6 million recorded in Q2 2025.
  • Rapid Micro Biosystems' Assets' 5-year high stood at $254.4 million during Q3 2021, with a 5-year trough of $75.6 million in Q2 2025.
  • In the last 5 years, Rapid Micro Biosystems' Assets had a median value of $146.8 million in 2023 and averaged $154.8 million.
  • As far as peak fluctuations go, Rapid Micro Biosystems' Assets skyrocketed by 24454.19% in 2021, and later crashed by 3544.35% in 2025.
  • Rapid Micro Biosystems' Assets (Quarter) stood at $241.2 million in 2021, then dropped by 20.95% to $190.6 million in 2022, then fell by 24.76% to $143.5 million in 2023, then tumbled by 31.57% to $98.2 million in 2024, then fell by 14.02% to $84.4 million in 2025.
  • Its last three reported values are $84.4 million in Q3 2025, $75.6 million for Q2 2025, and $85.4 million during Q1 2025.